Takeda Pharmaceuticals Co. Ltd., which manufactures of the best selling diabetes drugs in the world, is facing several hundreds of lawsuits due to recent reports that patients who take the bill for a year or longer may develop bladder cancer.
Actos was pulled from the market in Germany and France in June "after pressure from regulators" in the two countries, which raises the question of why the US has not halted sales of this highly profitable drug. FDA and the European Medicines Agency have "issued warnings about the cancer risk based on new research, but they have allowed sales to continue."
Jones Ward PLC's lawyers are experienced pharmaceutical injury lawyers. We are currently evaluating Actos bladder cancer cases. If you would like to have your case evaluated free of charge, feel free to contact us.
